Interferons Inhibit Ebola Virus Infection of Human Keratinocytes
Viruses · 02.12.2025 · 17 (12) · 1577
DOI: 10.3390/v17121577 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 02.12.2025. Verfasst von Jonah Elliff und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA. Hauptthemen laut MEDLINE: Keratinocytes, Ebolavirus, Interferons, Hemorrhagic Fever, Ebola. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH NIAID, National Institutes of Health.
Abstract (Originalsprache)
Orthoebolavirus zairense is the species name for Zaire Ebola virus (EBOV) within Filoviridae. This group of viruses can cause severe disease in humans, characterized by hemorrhagic shock, coagulation abnormalities, and severe inflammation. While tissue macrophages are critical targets early during EBOV infection, other cell types support viral replication as disease progresses. At late stages of infection, infectious EBOV is found on the surface of the skin, which may be a critical source of infectious virus transmitted between individuals during outbreaks. Human skin contains a number of cellular targets of EBOV, including keratinocytes. Here, we demonstrate EBOV infection of telomerase-immortalized normal human skin keratinocytes (NHSK-1), as well as EBOVΔVP30 infection of NHSK-1 cells that were stably complemented with EBOV transcription factor VP30. Infection with EBOVΔVP30 did not elicit detectable endogenous interferon responses; however, exogenous pre-treatment of NHSK-1 cells with type I, II, and III interferon (IFN) inhibited EBOVΔVP30 infection and infection of an additional low-containment model of EBOV, rVSV/EBOV GP, in a dose-dependent manner. Analysis of the transcriptome of IFN-treated keratinocytes identified multiple genes unique to each IFN and a subset of ISGs upregulated by all three IFNs. Our results indicate that ISGs induced by IFN pre-treatment of keratinocytes can reduce infection, underlining that ISGs may serve as EBOV-targeting therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, University of Iowa, Iowa City, IA 52242, USA.
- Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242, USA.
- Host Pathogens Interactions, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
- Department of Biology, Mt. Mercy College, Cedar Rapids, IA 52402, USA.
ORCID-Profile: Jonah Elliff, Hanora Van Ert, Marija Anne Djurkovic, Francoise Gourronc, Aloysius Klingelhutz, Olena Shtanko, Wendy Maury
Förderung
- NIAID NIH HHS
- NIH NIAID
- National Institutes of Health
- NIH
Zitieren
APA
Elliff, J., Van Ert, H., Sevcik, K., Djurkovic, M. A., Rudd, D., Gourronc, F., Klingelhutz, A., Shtanko, O., & Maury, W. (2025). Interferons Inhibit Ebola Virus Infection of Human Keratinocytes. Viruses, 17(12), 1577. https://doi.org/10.3390/v17121577
Vancouver
Elliff J, Van Ert H, Sevcik K, Djurkovic MA, Rudd D, Gourronc F, et al. Interferons Inhibit Ebola Virus Infection of Human Keratinocytes. Viruses. 2025;17(12):1577. doi:10.3390/v17121577
BibTeX
@article{Elliff2025,
author = {Elliff, Jonah and Van Ert, Hanora and Sevcik, Kristina and Djurkovic, Marija Anne and Rudd, Danielle and Gourronc, Francoise and Klingelhutz, Aloysius and Shtanko, Olena and Maury, Wendy},
title = {Interferons Inhibit Ebola Virus Infection of Human Keratinocytes},
journal = {Viruses},
year = {2025},
volume = {17},
number = {12},
pages = {1577},
doi = {10.3390/v17121577}
}
EUVIMED